/Bristol-Myers%20Squibb%20Co_%20logo%20on%20phone%20by-%20Piotr%20Swat%20via%20Shutterstock.jpg)
Based in Princeton, New Jersey, Bristol-Myers Squibb Company (BMY), with a market cap of $82 billion, is a global leader in biopharmaceuticals, specializing in treatments for serious diseases spanning oncology, immunology, cardiovascular, and fibrotic conditions. The biotech giant is expected to unveil its fiscal Q2 earnings results before the market opens on Friday, Jul. 26.
Prior to the event, analysts anticipate BMY to report a profit of $1.64 per share, reflecting a decrease of 6.3% from $1.75 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in three of the past four quarters while missing on one other occasion. The company reported a loss per share of $4.40 in the most recent quarter, surpassing the consensus loss per share estimate by a 3.3% margin due to lower charges for acquired research and development.